Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02307240
Title Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Curis, Inc.
Indications

breast cancer

ovarian cancer

Advanced Solid Tumor

triple-receptor negative breast cancer

NUT midline carcinoma

Therapies

CUDC-907

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCSF School of Medicine San Francisco California 94143 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field